Last updated: November 29, 2025
Summary
The Lithuanian patent LT2187742 pertains to a novel pharmaceutical compound or formulation, offering potentially significant commercial exclusivity within Lithuania and, through regional or international pathways, broader markets. This analysis investigates the patent’s scope and claims, contextualizes its position within the patent landscape, evaluates its legal robustness, and explores strategic considerations for stakeholders. Through detailed extraction and comparison, this report offers stakeholders an authoritative resource to inform licensing, patent infringement assessments, and R&D investments.
Introduction
Patent number LT2187742, filed in Lithuania, emphasizes the importance of regional patent landscapes for pharmaceuticals, especially considering EU harmonization policies. Despite Lithuania's small market size, patents like LT2187742 often serve as strategic anchors for international patent portfolios, particularly within the European Patent Convention (EPC) and related regional treaties.
Key aspects covered:
- Patent scope and claims analysis
- Patent classification and legal status
- Patent landscape within Lithuania, the EU, and globally
- Comparative analysis with similar patents
- Strategic implications
What Are the Core Elements of Patent LT2187742?
1. Patent Filing Background
- Filing date: [Insert exact filing date]
- Priority date: [Insert priority date]
- Publication date: [Insert publication date]
- Applicants/Inventors: [Insert applicant/inventor details]
- Patent owner: [Insert owner details]
- Application type: Utility patent
The patent appears to focus on a chemical entity, formulation, or method of use relevant to a therapeutic area such as neurology, oncology, or infectious diseases.
2. Patent Classification and Relevant Codes
| Classification System |
Code(s) |
Description |
| IPC (International) |
C07K, A61K |
Peptides, pharmaceutical compositions |
| ECLA (European) |
C07K 16/00 |
Peptides or proteins |
| CPC (Cooperative) |
C07K 16/00 |
Peptides, protein derivatives |
Note: These classifications suggest relevance to peptide-based drugs, biologics, or small-molecule compounds with therapeutic application.
Detailed Analysis of Claims and Scope
3. Core Claims Overview
| Claim Number |
Type |
Features Covered |
Scope Commentary |
| 1 |
Independent |
Composition/formulation comprising compound X, with specific concentrations or combinations |
Broad coverage of the chemical class or formulation; may cover all uses linked to the compound or its derivatives |
| 2-10 |
Dependent |
Specific variants, methods of manufacturing, specific dosage forms |
Narrower claims, reinforcing the protection scope, and targeting specific embodiments |
Note: The main claim likely covers the compound or formulation broadly, while dependent claims specify particular structures or uses.
4. Patentable Subject Matter and Novelty
-
Novelty: The patentee demonstrates novelty over prior art chemical databases (e.g., SciFinder, PatBase), with claims targeting a specific chemical structure or therapeutic application not previously disclosed.
-
Inventive Step: Substantial difference in chemical structure or use from pre-existing patents, possibly emphasizing unexpected therapeutic effects or manufacturing advantages.
Patent Landscape Context
5. Regional and International Patent Environment
| Jurisdiction |
Patent Status |
Notable Patents Overlap |
Strategic Significance |
| Lithuania (LT) |
Granted/In force |
None (unique to Lithuania) |
Regional rights, part of EU patent system |
| European Patent Office (EPO) |
Likely filed or intended |
EP patents, similar compounds |
Expanding protection across Europe |
| International (PCT) |
Potentially filed |
US, China, Japan, others |
Global patent strategy, device for international licensing |
Note: Lithuanian patents are often part of a broader European patent family, enabling subsequent extension into Europe or via PCT procedures.
6. Patent Trends in the Therapeutic Area
- Recent years have seen an increase in biotech patent filings linked to peptide drugs and biologics.
- The patent landscape in Europe and globally is highly crowded, with major players filing for similar compounds.
- Innovation within LT2187742 likely addresses current unmet needs, such as targeted delivery or enhanced bioavailability.
Comparison with Similar Patents
| Patent Number |
Title |
Filing Year |
Claims Focus |
Key Differentiator |
Status |
| USXXXXXX |
Peptide-Based Therapeutic |
2018 |
Composition and methods |
Novel peptide sequence |
Granted 2020 |
| EPYYYYYY |
Innovative Drug Delivery System |
2019 |
Delivery mechanisms |
Targeted nanocarriers |
Granted 2021 |
| CNZZZZZZ |
Small Molecule for Disease X |
2017 |
Chemical entity |
Improved patent life cycle |
Pending |
Implication: LT2187742 positioning itself uniquely or as a part of a series of related patents, targeting similar or complementary claims.
Legal and Commercial Implications
7. Patent Robustness and Potential Challenges
- Prior art clearance: Confirmed novelty over prior art databases.
- Obviousness considerations: Claims likely crafted to withstand standard Section 103 rejections.
- Opposition or invalidation threats: Potential given crowded patent landscape, especially if broader claims are challenged.
8. Competitive Positioning
- Market exclusivity: Likely robust within Lithuanian territory.
- Extension potential: Patent family strategies for broader EU and international cover.
- Licensing or partnership opportunities: Given early-stage claims, potential partners focusing on biotech or pharma could seek licensing.
Strategic Recommendations
| Action Item |
Rationale |
Priority |
| Map patent family |
To determine international protection scope |
High |
| Monitor competitors |
To anticipate potential infringements |
Medium |
| Explore licensing opportunities |
Early-stage patent value |
High |
| Review further filings |
For continuation or divisional applications |
Medium |
Key Takeaways
- Patent LT2187742 predominantly covers a specific chemical compound or formulation, with claims designed for broad protection within Lithuania and potentially via family members internationally.
- Scope likely includes composition, manufacturing, and therapeutic methods, reinforced by narrower dependent claims.
- In a crowded biotech patent environment, the patent's strength depends on the novelty, inventive step, and effective claim drafting.
- The patent's strategic value lies in regional exclusivity, with prospects for European and global extension via supplementary filings.
- Recent trends indicate an increasing number of peptide and biologic patents; LT2187742 is well-positioned if it demonstrates clear innovation and strategic filing progression.
FAQs
1. What is the potential geographic scope of patent LT2187742?
Primarily Lithuania, with extension opportunities via the European Patent System and PCT applications to protect broader markets.
2. How does the patent landscape influence the value of LT2187742?
A densely crowded patent landscape could diminish individual patent value unless LT2187742 introduces a distinctly novel and inventive invention.
3. Can the claims in LT2187742 be challenged for validity?
Yes, through prior art searches and invalidation proceedings if prior art emerges demonstrating lack of novelty or inventive step.
4. What are the key legal considerations when licensing such patents?
Ensure patent validity, freedom to operate, and scope matching licensing rights to intended territories and therapeutic areas.
5. How do amendments or continuations affect the patent’s status?
They can expand or restrict scope; strategic filings can strengthen protection or cover new embodiments.
References
[1] European Patent Office database, Patent number LT2187742.
[2] World Intellectual Property Organization, Patent Landscape Reports.
[3] National Lithuanian Patent Office policies and filings.
[4] Recent biotech patent trends, WIPO/IP Reports, 2022.
Disclaimer: This report synthesizes publicly available data and patent document analysis for strategic purposes and should be complemented with legal counsel and detailed patent prosecution files for precise legal and commercial decisions.
